Tags Posts tagged with "marijuana stocks 2017"

marijuana stocks 2017

0 1466
 

Testing Marijuana Potency In the Palm Of Your Hand

 

Producing your own cannabis-infused oils and tinctures for use in edibles can be a complex business. The potency of the herb you’re using can vary, and different oils will extract cannabinoids at different rates. Not knowing the strength of your recipe makes proper dosing of the final product a difficult endeavor.

 

 


Click Here Now To Read Full Article


 

Florida Legislators Reach an Agreement For Medical Marijuana Rules and Regulations

 

State legislators reached an agreement to make medical marijuana available in Florida, ending an impasse that hindered the issue last month. Reached Tuesday night after weeks of closed-door negotiations, the deal affirms the will of 71 percent of voters who approved a constitutional amendment to legalize medical marijuana back in November’s election that allowed patients with a host of conditions access to the drug.

 

 


Click Here Now To Read Full Article


 

Marijuana Industry Now Has A New Cryptocurrency

This morning, a Vancouver based company announced its second Initial Coin Offering (ICO). The cryptocurrency craze has been hot lately with many seeing uncapped potential within the market itself; bitcoin has taken a major role in this latest excitement. But now it looks like the marijuana industry could be ready to see a new currency.

 


Click Here Now To Read Full Article


0 556
marijuana stocks

Village Farms International And Emerald Health Form Joint Venture For Large-Scale Greenhouse Cannabis Production

– Transformational Opportunity Will See Conversion of Certain Village Farms’ BC Greenhouse Assets to An Economically Superior Product with Cannabis Production –

– Joint Venture Expects to be the Low-Cost Producer in the Canadian Cannabis Industry –

VANCOUVER, June 6, 2017 /CNW/ – Village Farms International, Inc. (“Village Farms”) (VFF.TO) (VFFIF) and Emerald Health Therapeutics Inc., together with its affiliates (“Emerald”) (EMH.V), today announced that they have entered into a definitive agreement to form a joint venture for large-scale, high-quality, low-cost cannabis production. Under the terms of the agreement, Village Farms will initially contribute a 1.1 million-square foot (25-acre) greenhouse facility in Delta, British Columbia, located on a 50-acre parcel of land (with ancillary buildings) (the “Initial Greenhouse”), which will be converted to ACMPR (Access to Cannabis for Medical Purposes Regulations)-compliant production and, if permitted by applicable law, production for the non-therapeutic adult-use market.

Emerald will initially contribute an aggregate of $20 million in cash (of which $2 million was advanced at closing and the remaining $18 million will be advanced in tranches upon satisfaction of certain milestones to be determined by the board of directors of the joint venture) to fund conversion of the Initial Greenhouse and each party will have a 50% ownership stake in the joint venture. (All figures are presented in Canadian dollars.)

Highlights of the Joint Venture Agreement

1.1 million square feet of initial potential greenhouse cannabis production (estimated to yield more than 75,000 kg of product annually) upon completion of full licencing and greenhouse conversion;

Formation of the joint venture is a transformational opportunity for Village Farms that will see the conversion of one of its existing Delta, BC greenhouse assets to grow a substantially more profitable agricultural product;
Village Farms is one of the largest, most experienced and technically advanced greenhouse growers in North America, with an ingrained culture of low-cost production;

Formation of the joint venture strategically positions Emerald for rapid production capacity expansion in partnership with world-class greenhouse operators, preparing it for the future non-therapeutic market and existing undersupplied medical cannabis market;

Emerald has significant cannabis industry experience, including a portfolio of high-quality genetics and refined standard operating procedures, with a flawless record of operations under Health Canada’s stringent ACMPR regime;
The joint venture has the goal to be the lowest-cost cannabis producer in Canada;

In the future, the joint venture has the potential to have access to up to 4.8 million square feet of greenhouse cannabis production (estimated to yield more than 300,000 kg of product annually), which would supply a considerable portion of the expected future cannabis demand in Canada or for export abroad;

The joint venture expects its production will address a diverse array of cannabis products, including dried cannabis and quality inputs for extraction-based products, currently the fastest growing segment in the Canadian medical cannabis market and expected to be a meaningful part of the non-therapeutic adult-use market; and,
Village Farms remains committed to its existing greenhouse produce business and customers.

“Diversification into cannabis production is a truly transformational opportunity for Village Farms, with a portion of its Canadian assets, to apply our core capabilities and expertise as a technology-driven, low-cost, high-quality greenhouse grower and our significant investment in our existing facilities to a product that is substantially more profitable,” said Michael DeGiglio, Chief Executive Officer of Village Farms International.

“Based on our conservative market pricing forecasts and yield projections, conversion of our Canadian greenhouse facilities to cannabis production could generate revenue of 10- to 15-times that of our current Canadian vegetable production with EBITDA margins potentially expanding to more than 50% compared with our current Canadian vegetable margins.” (See “Non-IFRS Measures” below.)

Village Farms will leverage the combined 750 years of experience of its master grower team, and its history and expertise as an established low-cost, high-quality greenhouse agricultural producer, within a vertically integrated business model. The goal of the joint venture is to be the lowest-cost, highest-quality cannabis producer in Canada, with a targeted production cost of less than $1.00 per gram.

Mr. DeGiglio continued, “Emerald is an excellent, and very complementary, partner for Village Farms in this endeavour, bringing with it a seasoned management team with specific cannabis industry experience, having obtained the eighth federal licence granted under the MMPR (now ACMPR) to cultivate medicinal cannabis. Emerald has tremendous downstream product development expertise and extensive experience in pharmaceutical and nutraceuticals product development for medical purposes. It is uniquely positioned in the Canadian cannabis industry, pursuing the development of cannabinoid medicines that are less toxic, more efficacious and safer therapeutic alternatives to conventional pharmaceutical medicines.”

“Partnering with Village Farms, one of North America’s largest and most technologically driven greenhouse growers, on this tremendous opportunity, is a very exciting development for Emerald,” said Avtar Dhillon, MD, Executive Chairman, Emerald Health Therapeutics. “Village Farms is a global leader in greenhouse growing and, importantly, an expert in the complex matter of safety for agricultural consumables, which is a critical competency in the production of cannabis. Together we have the experience, expertise, and capital to become not only Canada’s, but one of the world’s premier greenhouse cannabis growers.”

The transaction closed concurrently with the signing of a definitive agreement, at which time the joint venture leased (with the option to buy) Village Farms’ Delta 3 greenhouse assets. The joint venture also entered into an agreement with Village Farms for options to lease or purchase from Village Farms a second 1.1 million square foot greenhouse (25 acre) and a 2.6 million square foot (60 acre) greenhouse, both located adjacent to the Initial Greenhouse. Combined, these three greenhouse assets could provide the joint venture with a total potential aggregate production capacity of approximately 4.8 million square feet (110 acres).

Village Farms and Emerald believe currently announced planned production by licensed cannabis producers in Canada falls well short of the projected demand over the next four years following the anticipated legalization of non-therapeutic adult-use cannabis in Canada. The potential conversion of all of Village Farms’ Delta, BC greenhouse operations, if the applicable options were exercised, would conservatively be expected to yield approximately 300,000 kg of cannabis annually. Village Farms and Emerald believe this has the potential to fill a substantial portion of the potential Canadian production gap for both medical and non-therapeutic adult-use cannabis.

The joint venture will immediately initiate the process to obtain a Health Canada license to grow cannabis under ACMPR regulations and concurrently commence the process of converting the Initial Greenhouse for cannabis cultivation. Any additional capital requirements of the joint venture are to be contributed on a pro-rata basis by Village Farms and Emerald, or by outside third-party funding. (Please see “Forward Looking Statements” below.)

Advantages of Greenhouse Growing

Greenhouse growing has significant proven advantages over conventional indoor growing. Growing with natural sunlight produces a sustainable, high-quality product. Greenhouse growing requires substantially less energy inputs, which are costly to install and operate as well as not being environmentally sustainable. A large greenhouse footprint enables more efficient operating logistics and economies of scale all of which result in a significantly lower cost of production versus conventional (non-greenhouse) indoor growing. Greenhouse facilities also require substantially lower capital investment than conventional indoor growing facilities.

Village Farms is one of the most experienced, oldest and technologically-advanced greenhouse growers in the industry and one of the lowest-cost, highest-quality growers of hydroponic produce in the U.S. and Canada. It is also a leader in agricultural research and foremost in North America for developing record breaking greenhouse vegetable production technology in inhospitable climates. Its Applied Research Division continues to make meaningful advancements in the areas of Climate Engineering, Plant Biology & Pathology, Entomology, and Ecology.

Continued Commitment to Produce Business and Customers

Village Farms does not expect its growth of cannabis or other alternative crops to have a material impact on its existing produce production and distribution business.

“Although diversification into cannabis is a tremendous opportunity, we remain steadfastly committed to our existing produce business. We will continue to provide our customers with the premium-quality products they have come to know and expect throughout our 30-year history,” said Mr. DeGiglio. “In fact, the favourable economics of cannabis production are expected to provide Village Farms with the financial strength and resources necessary to further expand and solidify our industry-leading position. We fully expect to continue to expand capacity in our produce business to meet customer demand by exploring consolidation opportunities, as we have successfully done in the past, and through organic initiatives at our U.S. operations.

Financial and Legal Advisors

National Bank Financial acted as financial advisor and Torys LLP acted as legal advisor to Village Farms and McCullogh O’Connor Irwin LLP acted as legal advisor to Emerald with respect to the joint venture transaction.

Conference Call

Village Farms’ and Emerald’s management teams will host a joint conference call tomorrow, Wednesday, June 7, 2017, at 10:00 a.m. ET to discuss today’s announcement. Participants can access the conference call by dialing (647) 427-7450 or (888) 231-8191, or via the Internet at http://bit.ly/2qXtHYQ.

For those unable to participate in the conference call at the scheduled time, it will be archived for replay both by telephone and via the Internet beginning approximately one hour following completion of the call. To access the archived conference call by telephone, dial (416) 849-0833 or (866) 859-2056 and enter the passcode 35029750 followed by the pound key. The telephone replay will be available until Wednesday, June 14, 2017 at midnight. The conference call will also be archived on Village Farm’s web site at: http://villagefarms.com/investor-relations/investor-calls.

Material Change Report

Each of Village Farms and Emerald will file a material change report with the applicable Canadian securities regulators within 10 days of the date of this news release, both of which will be available under the respective issuer’s SEDAR profiles at www.sedar.com.

About Emerald Health Therapeutics Inc.

Emerald Health Therapeutics wholly owns Emerald Health Botanicals, which holds a license under the ACMPR to cultivate and sell medical cannabis flower and oils out of its facility located in Victoria, British Columbia. Emerald’s focus is on extraction and downstream product development, with a strategy including the purchase of cannabis from high quality low cost producers, such as the joint venture. Emerald is also developing 32 acres in the Lower Mainland (BC) to grow its unique strains of cannabis with the intention of treating medical conditions and developing consumer products.

About Village Farms International, Inc.

Village Farms International, Inc. is one of the largest and longest-operating vertically integrated greenhouse growers in North America and the only publicly traded greenhouse produce company in Canada. With more than 750 years of accumulated master grower experience coupled with advanced proprietary technology and environmentally sustainable growing practices, Village Farms is highly resource efficient. Village Farms produces and distributes fresh, premium-quality produce with consistency 365-days a year to national grocers in the U.S. and Canada from its large-scale Controlled Environment Agriculture (CEA) greenhouses in British Columbia and Texas, as well as from its partner greenhouses in BC, Ontario, and Mexico.

Cautionary Language

This press release contains certain “forward looking statements”. These statements relate to future events or future performance and reflect the various party’s expectations, results of operations, performance, business prospects, opportunities, industry performance and trends. These forward looking statements reflect the party’s current internal projections, expectations or beliefs and are based on information currently available. In some cases, forward looking statements can be identified by terminology such as “may”, “will”, “should”, “expect”, “plan”, “anticipate”, “believe”, “estimate”, “predict” , “potential”, “continue” or the negative of these terms or other comparable terminology. A number of factors could cause actual events or results to differ materially from the results discussed in the forward looking statements. In evaluating these statements, you should specifically consider various factors, including, but not limited to, such risks and uncertainties as the joint venture not obtaining the necessary Health Canada licenses, in which case the joint venture will not be permitted to grow cannabis under the ACMPR regulations, and the parties may elect to terminate the joint venture in accordance with its terms, availability of resources, other regulatory requirements and all of the other “Risk Factors” set out in the Village Farms’ and Emerald’s respective annual information forms and management’s discussion and analyses for the year ended December 31, 2016, and for the three-month period ended March 31, 2017, which are available electronically at www.sedar.com. Actual results may differ materially from any forward looking statement. Although Village Farms and Emerald believe that their respective forward looking statements contained in this press release are based upon reasonable assumptions, you cannot be assured that actual results will be consistent with these forward looking statements. These forward looking statements are made as of the date of this press release, and other than as specifically required by applicable law, neither Village Farms nor Emerald assume any obligation to update or revise them to reflect new information, events or circumstances.

Non-IFRS Measures

References in this press release to “EBITDA” are to earnings before interest, taxes, depreciation, amortization, foreign currency exchange gains and losses on translation of long-term debt, unrealized change in biological asset, stock compensation, and gains and losses on asset sales. EBITDA is a cash flow measure that is not recognized under IFRS and does not have a standardized meaning prescribed by IFRS. Therefore, EBITDA may not be comparable to similar measures presented by other issuers. Investors are cautioned that EBITDA should not be construed as an alternative to net income or loss determined in accordance with IFRS as an indicator of Village Farm’s performance or to cash flows from operating, investing and financing activities as measures of liquidity and cash flows. Management of Village Farms believes that EBITDA is an important measure in evaluating the historical performance of the Company.

0 3440
Marijuana-stocks-biotech

Marijuana stocks continue to trade volatile and Tetra Bio Pharma (TBP.CN) (TBPMF) has been one of the top performers recently. The shares rallied 22% last week and Tetra is well positioned to move significantly higher.

We recently highlighted Tetra Bio and want to provide an update on the company after last week’s move higher.

Continues to Strengthen Management Team

One of the major focuses of Tetra this year has been on its management team and earlier this month, the company added Dr. Bill Cheliak to its Board of Directors.

Dr. Cheliak is CEO of Panag Pharma, a Canadian based bio-tech company focused on the development of novel cannabinoid based formulations for the treatment of pain and inflammation. He has over 20 years of experience as an entrepreneur and brings extensive deal making experience to the company. Dr. Cheliak currently serves as a Director for Solarvest and is Vice Chair of the Government of Canada’s Networks Centers Excellence Standing Selection Committee and Chair of the NCE Monitoring Committee.

Earlier in May, Tetra Bio further strengthened its management team after it announced that Robert Bechard was appointed to the position of Vice President, Finance and Business Development.

A Focus on Cannabis Biotech Treatments

The addition of Dr. Bill Cheliak to the Board comes one-week after Tetra Bio signed a definitive agreement with Panag Pharma for the development and commercialization of novel cannabinoid based formulations for the treatment of pain and inflammation.

Per the definitive agreement, Tetra will have exclusive access to sell the ocular and topical drug products in North America with right of first negotiation for outside U.S. and Canadian territories. In addition, Tetra has a right of first negotiation for future cannabinoid-based products.

Tetra will work in close collaboration with Panag’s team of experts to ensure a rapid and successful development leading to marketing authorization. Panag will continue work in the development of novel products for unmet medical need and Tetra will take the lead in commercializing these novel drug products.

Positioned to Execute

The signing of a definitive agreement follows the submission of a provisional patent application with the U.S. Patent and Trademark Office (USPTO) for a pharmaceutical drug formulation to treat various forms of cancer and ocular disease

Tetra is focused on developing cannabinoid based pharmaceutical treatments for indications that are multi-billion-dollar opportunities and we think these steps have significantly improved the company’s position within the biotech sector. This is a stock to watch and one we suggest putting toward the top of your radar screens.


 

Disclaimer: Pursuant to an agreement between MAPH and Tetra Bio-Pharma, we were hired for a period of 90 days to publicly disseminate information about (TBPMF) including on the Website and other media including Facebook and Twitter. We are being paid $75,000 (CASH) for and were paid 250,000 restricted common shares of Tetra Bio-Pharma. We may buy or sell additional shares of (TBPMF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

0 1321

5 Benefits Of CBD

The emergence of the legal cannabis industry has created an unprecedented opportunity for investors. Although this burgeoning industry is already a multi-billion-dollar business, it is not even in the first inning of what will be multi-decade growth super cycle.


Click Here Now To Read Full Article


PotNetwork Holding, Inc. (POTN) : SeeThruEquity Initiates Coverage, Price Target of $0.25

PotNetwork Holding, Inc. (OTC PINK: POTN) is pleased to announce today that following the presentation at the 6th Annual SeeThruEquity’s Micro Cap Investor Conference, PotNetwork and Diamond CBD have been the highlight of a recent comprehensive research report projecting a price target of $0.25.


Click Here Now To Read Full (POTN) Release


 

Will Early Recreational Marijuana Sales Be A Reality for Nevada

Nevada’s idea of using its medical marijuana market to temporarily aid to the need of the recreational sector is set to launch sometime within the next month. Taken from a report from the Las Vegas Sun, there are more than 140 applicants vying to become the first to sell weed in a manner similar to beer.


Click Here Now To Read Full Article


 

mCig Inc. (MCIG ), Player’s Network, Inc. (PNTV ) Complete Phase 1 Construction for Production Facility

mCig Inc., ( OTCQB : MCIG ), a leading distributor of innovative products, technologies, and services for the global medical cannabis industry and Player’s Network, Inc. ( OTCQB : PNTV ), a diversified holding company operating in media and marijuana, today announce the Phase 1 completion of Green Leaf Farms Holdings, facility in North Las Vegas.


Click Here Now To Read Full Release


 

0 9838

When We Connect the Dots, You Profit 
Connect the Dots Articles Have Returned 9,932% for Our Readers 

Over the last couple years, as the marijuana industry has taken flight, it has been our mission to help our readers make money from cannabis. Every once in a while we publish a “Connect the Dots” article highlighting a company or group of companies that we believe have tremendous near-term upside potential. By identifying these companies and providing insight and research otherwise unavailable to the mainstream investor, we have been able to help our readers gain as much as 9,932% in about two and a half years. That is the combined gain percentage that all of our Connect the Dots companies experienced in the weeks and months after we published an article. Let’s take a look at some of our biggest gainers:

*CannaGrow Holdings (CGRW); previously BizAuctions (BZCN) click here for article
Connect the Dots published on 10/8/14 at $0.053
CGRW hit $3.45 on 10/18/16
6,409% gain 

*Rocky Mountain High (RMHB); previously Totally Hemp Crazy (THCZ) click here for article
Connect the Dots published on 12/18/14 at $0.0115
THCZ hit $0.32 on 4/1/15
2,683% gain

*Future Farm Technologies (FFRMF); previously Arcturus Growthstar Technologies (AGSTF) click here for article
Connect the Dots published on 10/4/16 at $0.137
FFRMF hit $0.541 on 2/22/17
295% gain

*Vitality Biopharma (VBIO) click here for article
Connect the Dots published on 12/6/16 at $1.01
VBIO hit $4.24 on 12/27/16
320% gain

These are just a few of our previous Connect the Dots highlights. And as you can see, the track record speaks for itself. It is our goal to literally connect the dots for our readers to help identify opportunity in this budding industry. And thus far we have done more than just identify opportunity; we have helped some earn a small fortune.

Now we know it’s impossible to have captured all of the 9,932% gains. So let’s say you were able to capture just half. A $5,000 investment would be worth $248,300. Again, that’s if you only captured half of the total gains.

The marijuana industry is at a very interesting stage of its development right now. Even with nearly 10,000% gains in the books, we still feel that we’ve only seen the tip of the iceberg. And it’s one mighty iceberg. We hope that you are happy with the content we provide and continue to read our articles on a daily basis. Because you never know when the next cannabis opportunity will bud.


Pursuant to an agreement between MAPH and Future Farm Inc., we were hired for a period of 30 days to publicly disseminate information about (FFRMF) including on the Website and other media including Facebook and Twitter. We are being paid $37,500 (CASH) for and were paid 1 million shares of restricted common shares. We may buy or sell additional shares of (FFRMF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.Pursuant to an agreement between MAPH and a non affiliate third party, we were previously hired for a period of 30 days to publicly disseminate information about (VBIO) including on the Website and other media including Facebook and Twitter. We were paid $100,000 (CASH) for or were paid “ZERO” shares of unrestricted or restricted common shares. We own zero shares of (VBIO) which we purchased in the open market. We may buy or sell additional shares of (VBIO) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

0 1700
marijuana

University Of Florida To Be Funded $2.5 Million For Medical Marijuana Research

 

A proposal that would award $2.5 million for UF to study medical marijuana recently moved forward in the Florida House of Representatives. The proposal states that money from the General Revenue Fund will be used to fund UF’s study on the safety and efficiency of medical cannabis. The bill, which passed through the Health Care Appropriations Subcommittee, moved into the Appropriations Committee on Friday.


Click Here Now To Read Full Article


 

Proposal In Nevada Aims To Loosen Cannabis Regulations

Senate Bill 329, introduced by Sen. Tick Segerblom, D-Las Vegas, would loosen some medical marijuana regulations, an idea Governor Brian Sandoval has stated his opposition to. Senate Bill 329 proposes a plethora of changes to how the state deals with cannabis. It would allow veterans to obtain a medical marijuana card, add PTSD to the list of conditions that qualify for those cards and even make it so cards do not need to be renewed. Medical cards now last 12 months in Nevada.


Click Here Now To Read Full Article


Lawmakers In West Virginia Look At Legalizing Industrial Hemp

 

Recently, Legislature sent separate proposals to the floor pushing for the legalization of commercial hemp production in West Virginia. Often, hemp is associated with marijuana. However, the new legislation declares hemp’s industrial uses. The bills state as long as the crop stays below a 1% threshold of tetrahydrocannabinol, the psychoactive component of cannabis, it can be produced after receiving licensing from the Agriculture Commissioner.


Click Here Now To Read Full Article


0 2097
cannabis biotech


$FFRMF Acquires High Volume, State-of-the-Art Cannabis Oil Extraction Equipment

 

Future Farm Technologies Inc. (the “Company” or “Future Farm”) (FFRMF) (FFT.CN) is pleased to announce that its majority owned subsidiary, FFM Consulting Services, LLC, has purchased a state-of-the-art extraction machine, for the manufacture of concentrated cannabis oil and purified distillate.

The equipment purchased is designed to rapidly manufacture premium cannabis oil, to supply the growing demand for cannabis concentrates, in the state of California. The equipment utilizes a closed-loop system, to produce high quality oil in a high throughput system with minimal maintenance and labor. The equipment is estimated to be delivered, installed and in full production within the next 90 days.

 


Click Here Now To Read Full PR


 

San Francisco May Form Cannabis Commission And Cannabis Department

 

Supervisor Jeff Sheehy, who Mayor Ed Lee appointed to the District 8 post in January, introduced legislation last week that would create a seven-member Cannabis Commission and Cannabis Department with a director and staff in San Francisco. The commission will decide whether to grant or deny permits related to commercial cannabis businesses as well as decide whether to suspend such permits based on yet-to-be-developed guidelines. San Francisco is currently working on regulations for the recreational cannabis industry after California voters legalized the substance by passing Proposition 64 back in November.


Click Here Now To Read Full Article


 

Marijuana Stocks Especially Cannabis-Biotechs are Capturing Wall Street’s Attention in a Big Way

Marijuana Stocks, especially Cannabis Companies with strong ties to Biotech have been increasingly front and center on Wall Street’s main stage. Marijuana Stocks and the Cannabis-Biotech sector continue to evolve and grow into the mainstream powerhouse we know it can and will be. We have identified a small Cannabis-Biotech start up that deserves your attention.


Click Here Now To Read Full Article


 

Pursuant to an agreement between MAPH and Future Farm Inc., we were hired for a period of 30 days to publicly disseminate information about (FFRMF) including on the Website and other media including Facebook and Twitter. We are being paid $37,500 (CASH) for and were paid 1 million shares of restricted common shares. We may buy or sell additional shares of (FFRMF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.PLEASE READ OUR FULL PRIVACY POLICY & TERMS OF USE & DISCLAIMER

0 2559

Marijuana Stocks, Inauguration Day, & Trump’s Bump

Here we are, just after the official inauguration day of our 45th President of the United States of America, Donald Trump. A lot has been said about him over the last few years during the election race but what many may not have expected was a clear “Trump Bump” for marijuana stocks.


Click Here To View Full Article


 

Facts Regarding Denver’s New Marijuana In Public Law

Denver has begun working on the country’s first law allowing use in public places like coffee shops and cannabis clubs. However, the details about what those marijuana clubs would look like are still unclear. Here are some answers to questions about the cannabis clubs headed to Denver.


Click Here To View Full Article


 

Veterans In Support Of Medical Marijuana



Indiana American Legion reached an agreement on Sunday that would support a medical cannabis study to treat injuries to military service members, such as traumatic brain injuries and PTSD. The veteran service organization said they are working to urge Indiana legislators to approve the private growth and research of medicinal cannabis and to reclassify marijuana as a drug with potential medical value.


Click Here To View Article


 

 

 PLEASE READ OUR FULL PRIVACY POLICY & TERMS OF USE & DISCLAIMER

3 25480

Today is the final trading day of the year will definitely be one that investors will always remember. The market remains in the positive as companies are better positioned for success. From the advance of the Canadian marijuana industry to election of Donald Trump, there will be a lot for investors to watch next year. We would like to highlight some themes anticipated to play out over 2017.

Consolidation

One of the brightest spots of the marijuana industry in 2016 was the Canadian licensed medical marijuana producer sub-sector. In early December, Mettrum Health (MT.V)(MQTRF) and Canopy Growth (CGC.TO)(TWMJF) announced an agreement where Canopy Growth will gain all of the outstanding shares of Mettrum.

Keep your eyes on the marijuana industry as it is expected to see more deals like this over the next year. The possibility for increase consolidation makes these companies attractive investment opportunities: Aphiria (APH.V)(APHQF), Supreme (SL.V)(SPRWF), OrganiGram (OGI.V)(ORGMF), Emblem Corporation (EMC.V), and Aurora Cannabis (ACB.V)(ACBFF).

Transformation

The biotech sector will be one of the greatest recipients of the legal marijuana movement and recent sector weakness has created opportunities for investors.
GW Pharmaceuticals (GWPH) reported its second Stage Three Clinical trial in September for its Epidiolex product for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS). We continue to view GWPH as one of the top marijuana investments due to its capability to convert the cannabis industry through the development of treatments for sickness’ that don’t currently have an approved regimen.

Execution

From the financial structure, investors need to conduct with earnestness. We suggest incorporating some guidelines into your investment blueprint.

To end 2016, we want to highlight some of the stocks investors should watch during next year: Emblem Corporation (EMC.V)(EMMBF), Zoned Properties (ZDPY), Aphria (APHQF), Kush Bottles (KSHB), American Cannabis (AMMJ), Aurora (ACBFF), Reliq Healthcare (RQHTF), Zynerba Pharmaceuticals (ZYNE), OrganiGram (OG.V)(ORGMF), Arcturus Grothstar Tech (AGSTF), MassRoots (MSRT), VPR Brands (VPRB), CV Sciences (CVSI), mCig (MCIG), Canopy Growth (TWMJF)(CGC.TO), Medicine Man Tech (MDCL), GW Pharmaceuticals (GWPH), Lexaria (LXRP), Canabo Medical (CMM.V)(CAMDF), Mettrum Health (MT.V), and VinergyRes (VIN.CN).

0 47135
marijuana

One of the biggest questions we get on MarijuanaStocks.com is “How do I buy Marijuana Stocks?” First, we aren’t financial advisors, but we can offer you a good starting point and some relevant information. We get thousands of emails from our subscribers and created this based off of your inquiries. MarijuanaStocks.com hopes this is a helpful guide to potential investors interested in the Cannabis sector, but we encourage you to continue your research and hopefully you’ll become the next Pot Stock millionaire! Cheers

Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Marijuana Stocks, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact privacy@marijuanastocks.com
Ad Placements